Conmed (CNMD) Total Liabilities (2010 - 2026)

Conmed (CNMD) has reported Total Liabilities for 17 consecutive years, with $1.3 billion the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, Total Liabilities fell 5.03% year-over-year to $1.3 billion; the trailing twelve-month figure through Jun 2026 stood at $1.3 billion (down 5.03% YoY), and the FY2025 full-year result was $1.3 billion, down 3.79% from the prior year.
• Total Liabilities fell to $1.3 billion in Q2 2026 per CNMD's latest filing, from $1.3 billion in the prior quarter.
• Across five years, Total Liabilities topped out at $1.6 billion in Q3 2022 and bottomed at $996.2 million in Q1 2022.
• Historically, Total Liabilities has averaged $1.4 billion across 5 years, with a median of $1.4 billion in 2022.
• The sharpest annual moves came in 2022 and 2024: Total Liabilities surged 58.28% in 2022, then slipped 9.59% in 2024.
• Over 5 years, Total Liabilities stood at $1.6 billion in 2022, then retreated by 5.56% to $1.5 billion in 2023, then fell by 8.34% to $1.3 billion in 2024, then slipped by 3.79% to $1.3 billion in 2025, then fell by 2.61% to $1.3 billion in 2026.
• According to Business Quant data, Total Liabilities over the past three periods registered $1.3 billion, $1.3 billion, and $1.3 billion for Q2 2026, Q1 2026, and Q4 2025 respectively.